A partnership that benefits patients
What is a clinical trial and how to participate.
Look at our future science
Review our clinical pipeline
What is a clinical trial and how to participate
We have teamed up with the International Red Cross and Red Crescent Movement to solve the challenge of delivering care to vulnerable populations displaced by conflict.
Click through to find the answers to some of our more frequently asked questions on sustainability and responsible business practices.
We are driven by science, innovation and research and strive to share our knowledge with the global community.
Staten Biotechnology B.V. and Novo Nordisk A/S announce collaboration to develop ... Read more
Oral semaglutide demonstrates favourable cardiovascular safety profile and signi ... Read more
Oral semaglutide demonstrates greater reductions in both HbA1c and body weight c ... Read more
Embark and Novo Nordisk enter collaboration to discover novel therapeutics for o ... Read more
Novo Nordisk A/S - Share repurchase programme ... Read more
Novo Nordisk A/S: Share repurchase programme ... Read more
Financial statement for the full year of 2018,
Cut-off date for shareholders' proposals in connection with the Annual General Meeting (AGM), Copenhagen
Annual General Meeting, Copenhagen
Financial statement for the first three months of 2019,
Take an advanced view of the Novo Nordisk share
Click here to find further information
Link to conference call and presentation
Read about Novo Nordisk – A focused healthcare company
See relevant content for private investors
Download relevant Investor Relations material
Peter Hugreffe AnkersenHead of Investor Relations
Anders Mikkelsen Investor Relations Manager
Valdemar Borum Svarrer Investor Relations Manager
Kristoffer Due Berg Investor Relations Manager
Chilie Thomsen Investor Relations Coordinator
Sign up to receive company announcements.
Link to webcast and presentation
